Ondine Biomedical Inc. (OBI.L)
GBp 8.13
(4.84%)
GBp 8.13
(4.84%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.73 Million CAD | -65.39% |
| 2022 | 16.56 Million CAD | -51.47% |
| 2021 | 34.14 Million CAD | 1195.64% |
| 2020 | 2.63 Million CAD | -9.54% |
| 2019 | 2.91 Million CAD | -35.24% |
| 2018 | 4.49 Million CAD | -19.79% |
| 2017 | 5.6 Million CAD | 0.0% |
| 2010 | 2.53 Million CAD | -3.25% |
| 2009 | 2.61 Million CAD | -11.11% |
| 2008 | 2.94 Million CAD | -77.34% |
| 2007 | 13 Million CAD | -29.57% |
| 2006 | 18.46 Million CAD | 7.04% |
| 2005 | 17.24 Million CAD | 0.0% |
| 2003 | 6364.00 CAD | 650.47% |
| 2002 | 848.00 CAD | -99.94% |
| 2001 | 1.45 Million CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q2 | 7.4 Million CAD | 0.0% |
| 2023 Q4 | 5.73 Million CAD | 0.0% |
| 2023 FY | 5.73 Million CAD | -65.39% |
| 2022 Q2 | 25.31 Million CAD | 0.0% |
| 2022 FY | 16.56 Million CAD | -51.47% |
| 2022 Q4 | 16.56 Million CAD | 0.0% |
| 2021 Q2 | 2.55 Million CAD | 0.0% |
| 2021 FY | 34.14 Million CAD | 1195.64% |
| 2021 Q4 | 34.14 Million CAD | 0.0% |
| 2020 Q4 | 2.63 Million CAD | 0.0% |
| 2020 FY | 2.63 Million CAD | -9.54% |
| 2019 FY | 2.91 Million CAD | -35.24% |
| 2018 FY | 4.49 Million CAD | -19.79% |
| 2017 FY | 5.6 Million CAD | 0.0% |
| 2011 Q2 | 2.39 Million CAD | 17.22% |
| 2011 Q1 | 2.04 Million CAD | -19.3% |
| 2010 Q3 | 2.17 Million CAD | -5.01% |
| 2010 Q1 | 2.75 Million CAD | 5.2% |
| 2010 FY | 2.53 Million CAD | -3.25% |
| 2010 Q2 | 2.29 Million CAD | -16.78% |
| 2010 Q4 | 2.53 Million CAD | 16.34% |
| 2009 Q4 | 2.61 Million CAD | -3.12% |
| 2009 FY | 2.61 Million CAD | -11.11% |
| 2009 Q1 | 2.14 Million CAD | -27.14% |
| 2009 Q3 | 2.7 Million CAD | -39.87% |
| 2009 Q2 | 4.49 Million CAD | 109.43% |
| 2008 Q4 | 2.94 Million CAD | -37.4% |
| 2008 FY | 2.94 Million CAD | -77.34% |
| 2008 Q1 | 10.11 Million CAD | -22.21% |
| 2008 Q2 | 7.81 Million CAD | -22.73% |
| 2008 Q3 | 4.7 Million CAD | -39.79% |
| 2007 Q3 | 8.74 Million CAD | -25.5% |
| 2007 Q4 | 13 Million CAD | 48.63% |
| 2007 Q2 | 11.74 Million CAD | -21.69% |
| 2007 Q1 | 14.99 Million CAD | -18.78% |
| 2007 FY | 13 Million CAD | -29.57% |
| 2006 FY | 18.46 Million CAD | 7.04% |
| 2006 Q4 | 18.46 Million CAD | 57.36% |
| 2006 Q3 | 11.73 Million CAD | -17.81% |
| 2006 Q2 | 14.27 Million CAD | -13.56% |
| 2006 Q1 | 16.51 Million CAD | -4.25% |
| 2005 Q1 | 12.3 Million CAD | -9.88% |
| 2005 Q4 | 17.24 Million CAD | -11.6% |
| 2005 Q3 | 19.51 Million CAD | -7.98% |
| 2005 Q2 | 21.2 Million CAD | 72.27% |
| 2005 FY | 17.24 Million CAD | 0.0% |
| 2004 Q3 | 15.34 Million CAD | -9.41% |
| 2004 Q2 | 16.94 Million CAD | 537.99% |
| 2004 Q1 | 2.65 Million CAD | 1.66% |
| 2004 Q4 | 13.65 Million CAD | -11.02% |
| 2003 Q4 | 2.61 Million CAD | 40950.28% |
| 2003 FY | 6364.00 CAD | 650.47% |
| 2003 Q1 | 2251.00 CAD | -60.51% |
| 2003 Q3 | 6364.00 CAD | 14.96% |
| 2003 Q2 | 5536.00 CAD | 145.94% |
| 2002 FY | 848.00 CAD | -99.94% |
| 2002 Q2 | 1.48 Million CAD | 2.24% |
| 2002 Q3 | 848.00 CAD | -99.94% |
| 2002 Q4 | 5700.00 CAD | 572.17% |
| 2002 Q1 | 1.44 Million CAD | -0.04% |
| 2001 Q4 | 1.44 Million CAD | 0.0% |
| 2001 FY | 1.45 Million CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|